|
GH/UW Verification |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
Group Health and University of Washington |
Case, Control |
479 |
319 |
100%, 100% |
100%, 100% |
|
Mayo Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
|
Case, Control |
416 |
278 |
|
|
|
GERD Implementation - Columbia |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
Columbia University |
Case, Control |
76 |
259 |
|
|
|
CKD_Columbia University |
Chronic Kidney Disease |
Columbia University |
Case, Control |
2,019 |
256 |
|
|
|
Columbia University - AFH Implementation |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Columbia University Medical Center |
Case, Control |
17 |
256 |
|
|
|
Epilepsy Part I - Columbia |
Epilepsy/Antiepileptic drug response algorithm |
Columbia University |
Case, Control |
2 |
244 |
|
|
|
Atopic Dermatitis - Columbia |
Atopic Dermatitis Algorithm |
Columbia University |
Case, Control |
7 |
238 |
|
|
|
ACEi Cough Implementation - Columbia |
ACE Inhibitor (ACE-I) induced cough |
Columbia University |
Case, Control |
17 |
233 |
|
|
|
CHOP eM3 |
Clostridium Difficile Colitis |
CHOP |
Case, Control |
104 |
214 |
|
|
|
Group Health Implementation of Atopic Dermatitis Algorithm |
Atopic Dermatitis Algorithm |
Group Health Cooperative |
Case, Control |
206 |
207 |
100%, 100% |
100% |
|
CDiff Implementation - Columbia |
Clostridium Difficile Colitis |
Columbia University |
Case, Control |
107 |
139 |
|
|
|
Nortwestern University e3 Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Northwestern University |
Case, Control |
48 |
133 |
|
|
|
Hypothyroidism Implementation - Columbia |
Hypothyroidism |
Columbia University |
Case, Control |
45 |
129 |
|
|
|
CKD_CHOP |
Chronic Kidney Disease |
CHOP |
Case, Control |
84 |
80 |
|
|
|
Breast Cancer_Columbia |
Breast Cancer |
Columbia University |
Case, Control |
87 |
79 |
94%, 99% |
|
|
Marshfield diverticulosis/diverticulitis implementation |
Diverticulosis and Diverticulitis |
Marshfield Clinic Research Foundation |
Case, Control |
50 |
50 |
100%, 100% |
|
|
Northwestern University Validation |
Colorectal Cancer (CRC) |
Northwestern University |
Case, Control |
50 |
50 |
86%, 98% |
92% |
|
Marshfield Venous Thromboembolism implementation |
Venous Thromboembolism (VTE) |
Marshfield Clinic Research Foundation |
Case, Control |
50 |
49 |
98%, 100% |
|
|
Mayo FH Implementation |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Mayo Clinic |
Case, Control |
58 |
42 |
100%, 98% |
100%, 100% |
|
Columbia - AID Phenotype |
Autoimmune Disease Phenotype |
Columbia University |
Case, Control |
132 |
29 |
86%, 93% |
|
|
Geisinger Zoster Implementation |
Herpes Zoster |
Geisinger |
Case, Control |
27 |
27 |
89%, 96% |
100% |
|
Group Health and UW Zoster Implementation |
Herpes Zoster |
Group Health and UW |
Case, Control |
25 |
25 |
100%, 96% |
100% |
|
Marshfield Hearing loss validation |
Hearing Loss |
Marshfield Clinic Research Foundation |
Case, Control |
25 |
25 |
100%, 100% |
|
|
Group Health/University of Washington CRC Validation |
Colorectal Cancer (CRC) |
GH/UW |
Case, Control |
25 |
25 |
92%, 100% |
100%, 100% |
|
Statin and MACE Mount Sinai Implementation |
Statins and MACE |
Mount Sinai |
Case Only |
52 |
25 |
96%, 100% |
100%, 100% |
